Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough.
Kita
Toshiyuki
T
Department of Respiratory Medicine, National Hospital Organization Kanazawa Medical Center, Toyama, Japan. naika-k1@kinbyou.hosp.go.jp
Fujimura
Masaki
M
Ogawa
Haruhiko
H
Nakatsumi
Yasuto
Y
Nomura
Satoshi
S
Ishiura
Yoshihisa
Y
Myou
Shigeharu
S
Nakao
Shinji
S
D000085:Acetates / Q000008:administration & dosage* / Q000009:adverse effects; D000328:Adult; D000368:Aged; D000996:Antitussive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D002976:Clenbuterol / Q000008:administration & dosage* / Q000009:adverse effects; D003371:Cough; D003521:Cyclopropanes; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D020024:Leukotriene Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D011804:Quinolines / Q000008:administration & dosage* / Q000009:adverse effects; D012129:Respiratory Function Tests; D013440:Sulfides; D016896:Treatment Outcome
D000085:Acetates; D000996:Antitussive Agents; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast; D002976:Clenbuterol